Clipping of news on Brazilian Culture, Law and Citizenship
08/05/2012
This article was translated by an automatic translation system, and was therefore not reviewed by people.
Medication is the most widely used in AIDS treatment
The government extended for five years the duration of compulsory licensing of patents relating to Efavirenz for non-commercial public use. The measure takes effect from today (7), with the publication of the decree in the Official Gazette antiretroviral Efavirenz is the most imported product used to treat AIDS and distributed network of SUS (Unified Health System).
Compulsory licensing was first enacted in May 2007, the Brazilian government to allow the importation of generic versions of Efavirenz from laboratories pre-qualified by WHO (World Health Organization). It can be implemented based on the circumstances foreseen in Industrial Property Law of the country as poor marketing or national emergency and public interest.
In the case of efavirenz, the measure was taken because Merck, the patent holder has not accepted the proposal to reduce price that was satisfactory to Brazil, one of the biggest global buyers of the product.
Source: R7 News
Our news are taken in full of our partner sites. For this reason, we can not change the content of these up in case of typing errors.
This article was translated by an automatic translation system, and was therefore not reviewed by people.